Generalized Anxiety Disorder Market - Forecast (2021 - 2026)
According to the World Health Organization (WHO) in 2017 approximately 300 million people were suffering from depression across the globe. Anxiety disorders are characterized by uncontrollable worry about daily events in a person’s life. Significant rise in the number of people suffering from generalized anxiety disorder has led to the growth of therapeutics market. The market would generate over $7.4 billion in revenues by 2023 at a CAGR of over 2.5% over the forecast period 2018-2023. The increase in the development and production of various drugs in this area is considered as one of the reasons for the market growth. On other hand, anxiety therapies and devices segment is growing with a remarkable Cumulative Annual Growth Rate owing to its high efficiency in treating anxiety related disorders and increasing demand.
Request Sample
What is Generalized Anxiety Disorder?
Anxiety disorders are characterized by uncontrollable worry about daily events in a person’s life. The different kinds of anxiety include generalized anxiety disorder, panic disorder, specific phobias, agoraphobia, social anxiety disorder and separation anxiety disorder.
Generalized anxiety disorder (GAD) includes certain symptoms such as headache, tension, profuse sweating and tiredness. It has been observed that GAD occurs along with other anxiety disorder and depression. A large number of factors are responsible for the occurrence of GAD such as genetics, brain chemistry, and exposure to stressful event, family background, or life experiences.
Inquiry Before Buying
This report incorporates an in-depth assessment of generalized anxiety disorder market by therapeutics type, therapies, devices and geography.
Market Research and Market Trends of Generalized Anxiety Disorder:
Fisher Wallace Simulator, an FDA-approved neurostimulation device to help treat depression, anxiety and insomnia. It is headband like device which stimulates the brain to release certain hormones such as dopamine which is known to reduce stress. Fisher Wallace Stimulator makes it possible to sit at home and engage in neurostimulation therapy. This can help patients to be naturally treated with the same effect as that of an antidepressant.
Scientists are currently working on finding the biomarkers that will categorize anxiety disorders more accurately. This data would help to understand the response of each drug to a particular disorder and thus could help to push therapeutic research forward driving the market during the forecast period.
Aloradine, a nasal spray-delivered agent, has a novel mechanism of action that stimulates nasal chemoreceptors. This transmits messages rapidly to the brain’s limbic system, amygdala and hypothalamus directly modulating brain autonomic, psychophysiological, and neuroendocrine responses and reducing stress and anxiety. This drug can be self-administered using a simple, low-cost device.
Currently, there is a lot of research going on to qualify a probiotic as a psychobiotic which would specifically provide mental health benefits. The effect of psychobiotic in the intestine would be conveyed to the brain and the other organs by the vagus nerve which is known to have a link between the nervous system and the digestive system.
Request Sample
What is Generalized Anxiety Disorder?
Anxiety disorders are characterized by uncontrollable worry about daily events in a person’s life. The different kinds of anxiety include generalized anxiety disorder, panic disorder, specific phobias, agoraphobia, social anxiety disorder and separation anxiety disorder.
Generalized anxiety disorder (GAD) includes certain symptoms such as headache, tension, profuse sweating and tiredness. It has been observed that GAD occurs along with other anxiety disorder and depression. A large number of factors are responsible for the occurrence of GAD such as genetics, brain chemistry, and exposure to stressful event, family background, or life experiences.
Inquiry Before Buying
This report incorporates an in-depth assessment of generalized anxiety disorder market by therapeutics type, therapies, devices and geography.
Market Research and Market Trends of Generalized Anxiety Disorder:
Fisher Wallace Simulator, an FDA-approved neurostimulation device to help treat depression, anxiety and insomnia. It is headband like device which stimulates the brain to release certain hormones such as dopamine which is known to reduce stress. Fisher Wallace Stimulator makes it possible to sit at home and engage in neurostimulation therapy. This can help patients to be naturally treated with the same effect as that of an antidepressant.
Scientists are currently working on finding the biomarkers that will categorize anxiety disorders more accurately. This data would help to understand the response of each drug to a particular disorder and thus could help to push therapeutic research forward driving the market during the forecast period.
Aloradine, a nasal spray-delivered agent, has a novel mechanism of action that stimulates nasal chemoreceptors. This transmits messages rapidly to the brain’s limbic system, amygdala and hypothalamus directly modulating brain autonomic, psychophysiological, and neuroendocrine responses and reducing stress and anxiety. This drug can be self-administered using a simple, low-cost device.
Currently, there is a lot of research going on to qualify a probiotic as a psychobiotic which would specifically provide mental health benefits. The effect of psychobiotic in the intestine would be conveyed to the brain and the other organs by the vagus nerve which is known to have a link between the nervous system and the digestive system.
"We also publish more than 100 reports every month in "Lifesciences and Healthcare ", Go through the Domain if there are any other areas for which you would like to get a market research study."
Comments
Post a Comment